KCNJ9 Antikörper (FITC)
Kurzübersicht für KCNJ9 Antikörper (FITC) (ABIN2746641)
Target
Alle KCNJ9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Affinity Purified
-
Immunogen
- Synthetic peptide corresponding to unique amino acid region on human GIRK3 protein.
-
Isotyp
- IgG
-
-
anti-Potassium Inwardly-Rectifying Channel, Subfamily J, Member 9 (KCNJ9) (C-Term) antibody
KCNJ9 Reaktivität: Human, Maus, Ratte WB, ELISA, ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Potassium Inwardly-Rectifying Channel, Subfamily J, Member 9 (KCNJ9) (AA 61-110) antibodyKCNJ9 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Potassium Inwardly-Rectifying Channel, Subfamily J, Member 9 (KCNJ9) (AA 287-336) antibodyKCNJ9 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Schwein, Meerschweinchen, Hamster, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Potassium Inwardly-Rectifying Channel, Subfamily J, Member 9 (KCNJ9) (Middle Region) antibodyKCNJ9 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Hund, Ziege, Pferd, Kaninchen, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
anti-Potassium Inwardly-Rectifying Channel, Subfamily J, Member 9 (KCNJ9) (AA 344-361), (Intracellular) antibodyKO Validated KCNJ9 Reaktivität: Ratte WB, IHC, IF, IC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.55-0.59 μg/μL
-
-
-
